{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:25:30Z","timestamp":1746303930439,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T00:00:00Z","timestamp":1481328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#FRN-83518"],"award-info":[{"award-number":["#FRN-83518"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10067-016-3501-9","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T09:17:51Z","timestamp":1481361471000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients"],"prefix":"10.1007","volume":"36","author":[{"name":"and the Canadian Scleroderma Research Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Levis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Kwakkenbos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett D.","family":"Thombs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,10]]},"reference":[{"key":"3501_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/cs0990001","volume":"99","author":"MG Swain","year":"2000","unstructured":"Swain MG (2000) Fatigue in chronic disease. Clin Sci 99:1\u20138","journal-title":"Clin Sci"},{"key":"3501_CR2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","volume":"50","author":"M Bassel","year":"2011","unstructured":"Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD (2011) Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian national survey. Rheumatology 50:762\u2013767","journal-title":"Rheumatology"},{"key":"3501_CR3","first-page":"S88","volume":"32","author":"LM Willems","year":"2014","unstructured":"Willems LM, Kwakkenbos L, Leite C, Thombs BD, van den Hoogen FHJ, Maia A, Vliet-Vlieland TPM, van den Ende CHM (2014) Frequency and impact of disease symptoms experienced by patients with systemic sclerosis from five European countries. Clin Exp Rheum 32:S88\u2013S93","journal-title":"Clin Exp Rheum"},{"key":"3501_CR4","first-page":"1279","volume-title":"Kelley\u2019s textbook of rheumatology","author":"J Seibold","year":"2005","unstructured":"Seibold J (2005) Scleroderma. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB (eds) Kelley\u2019s textbook of rheumatology, 7th edn. Elsevier, Philadelphia, pp. 1279\u20131308","edition":"7th"},{"key":"3501_CR5","first-page":"1463","volume-title":"Rheumatology","author":"FM Wigley","year":"2003","unstructured":"Wigley FM, Hummers LK (2003) Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weismann WH (eds) Rheumatology, 3rd edn. Mosby, Philadelphia, pp. 1463\u20131480","edition":"3rd"},{"key":"3501_CR6","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246\u20132255","journal-title":"Arthritis Rheum"},{"key":"3501_CR7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/acr.20187","volume":"62","author":"BD Thombs","year":"2010","unstructured":"Thombs BD, van Lankveld W, Bassel M et al (2010) Psychological health and well-being in systemic sclerosis: state of the science and consensus research agenda. Arthritis Care Res 62:1181\u20131189","journal-title":"Arthritis Care Res"},{"key":"3501_CR8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000434666.47397.c2","volume":"25","author":"VL Malcarne","year":"2013","unstructured":"Malcarne VL, Fox RS, Mills SD, Gholizadeh S (2013) Psychosocial aspects of systemic sclerosis. Curr Opin Rheumatol 25:707\u2013713","journal-title":"Curr Opin Rheumatol"},{"key":"3501_CR9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/art.11385","volume":"49","author":"HL Richards","year":"2003","unstructured":"Richards HL, Herrick AL, Griffin K, Gwilliam PD, Loukes J, Fortune DG (2003) Systemic sclerosis: patients\u2019 perceptions of their condition. Arthritis Rheum 49:689\u2013696","journal-title":"Arthritis Rheum"},{"key":"3501_CR10","unstructured":"Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M (2007) Disease and symptom burden in systemic sclerosis: a patient perspective. J Rheumatol:1718\u20131726"},{"key":"3501_CR11","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/rheumatology\/kem008","volume":"46","author":"WG Lankveld van","year":"2007","unstructured":"van Lankveld WG, Vonk MC, Teunissen H, van den Hoogen FH (2007) Appearance self-esteem in systemic sclerosis-subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology 46:872\u2013876","journal-title":"Rheumatology"},{"key":"3501_CR12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10067-015-3035-6","volume":"35","author":"CL Overman","year":"2016","unstructured":"Overman CL, Kool MB, Da Silva JA, Geenen R (2016) The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol 35:409\u2013415","journal-title":"Clin Rheumatol"},{"key":"3501_CR13","doi-asserted-by":"crossref","first-page":"e26061","DOI":"10.1371\/journal.pone.0026061","volume":"6","author":"S Assassi","year":"2011","unstructured":"Assassi S, Leyva AL, Mayes MD et al (2011) Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. PLoS One 6:e26061","journal-title":"PLoS One"},{"key":"3501_CR14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/art.24614","volume":"61","author":"BD Thombs","year":"2009","unstructured":"Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M, Canadian Scleroderma Research Group (2009) Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 61:966\u2013973","journal-title":"Arthritis Rheum"},{"key":"3501_CR15","first-page":"411","volume":"66","author":"MA Babyak","year":"2004","unstructured":"Babyak MA (2004) What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66:411\u2013421","journal-title":"Psychosom Med"},{"key":"3501_CR16","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/kes206","volume":"51","author":"D Harel","year":"2012","unstructured":"Harel D, Thombs BD, Hudson M, Baron M, Steele R, Canadian Scleroderma Research Group (2012) Measuring fatigue in SSc: a comparison of the Short Form-36 Vitality subscale and Functional Assessment of Chronic Illness Therapy-Fatigue scale. Rheumatology 51:2177\u20132185","journal-title":"Rheumatology"},{"key":"3501_CR17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/acr.22451","volume":"67","author":"H Alhajeri","year":"2015","unstructured":"Alhajeri H, Hudson M, Fritzler M, Pope J, Tatibouet S, Markland J et al (2015) The 2013 ACR\/EULAR classification criteria for systemic sclerosis out-perform the 1980 criteria. Data from the Canadian Scleroderma Research Group. Arthritis Care Res 67:582\u2013587","journal-title":"Arthritis Care Res"},{"key":"3501_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag 13:63\u201374","journal-title":"J Pain Symptom Manag"},{"key":"3501_CR19","first-page":"811","volume":"32","author":"D Cella","year":"2005","unstructured":"Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32:811\u2013819","journal-title":"J Rheumatol"},{"key":"3501_CR20","doi-asserted-by":"crossref","first-page":"e91979","DOI":"10.1371\/journal.pone.0091979","volume":"9","author":"L Kwakkenbos","year":"2014","unstructured":"Kwakkenbos L, Willems LM, Baron M, Hudson M, Cella D, van den Ende CH, Thombs BD, Canadian Scleroderma Research Group (2014) The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis. PLoS One 9:e91979","journal-title":"PLoS One"},{"key":"3501_CR21","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281\u20131285","journal-title":"J Rheumatol"},{"key":"3501_CR22","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"3501_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","volume":"40","author":"E Hachulla","year":"2011","unstructured":"Hachulla E, Launay D (2011) Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 40:78\u201383","journal-title":"Clin Rev Allergy Immunol"},{"key":"3501_CR24","first-page":"2159","volume":"26","author":"TA Medsger Jr","year":"1999","unstructured":"Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159\u20132167","journal-title":"J Rheumatol"},{"key":"3501_CR25","first-page":"S42","volume":"21","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21:S42\u2013S46","journal-title":"Clin Exp Rheumatol"},{"key":"3501_CR26","first-page":"2218","volume":"34","author":"M Hudson","year":"2007","unstructured":"Hudson M, Walker JG, Fritzler M, Taillefer S, Baron M (2007) Hypocomplementemia in systemic sclerosis\u2014clinical and serological correlations. J Rheumatol 34:2218\u20132223","journal-title":"J Rheumatol"},{"key":"3501_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005650-199601000-00006","volume":"34","author":"JN Katz","year":"1996","unstructured":"Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73\u201384","journal-title":"Med Care"},{"key":"3501_CR28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"3501_CR29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385\u2013401","journal-title":"Appl Psychol Meas"},{"key":"3501_CR30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/art.23524","volume":"59","author":"BD Thombs","year":"2008","unstructured":"Thombs BD, Hudson M, Taillefer SS, Baron M (2008) Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 59:504\u2013509","journal-title":"Arthritis Rheum"},{"key":"3501_CR31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0304-3959(00)00459-0","volume":"91","author":"MP Jensen","year":"2001","unstructured":"Jensen MP, Smith DG, Ehde DM, Robinsin LR (2001) Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain. Pain 91:317\u2013322","journal-title":"Pain"},{"key":"3501_CR32","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3899\/jrheum.100354","volume":"37","author":"M Hudson","year":"2010","unstructured":"Hudson M, Impens A, Baron M, Seibold JR, Thombs BD, Walker JG, Canadian Scleroderma Research Group, Steele R (2010) Discordance between patient and physician assessments of disease severity in systemic sclerosis. J Rheumatol 37:2307\u20132312","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3501-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3501-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3501-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:40:49Z","timestamp":1498354849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3501-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,10]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3501"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3501-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2016,12,10]]}}}